Danhauser-Riedl S - Search Results

1

Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.

Hallek M, Neumann C, Schäffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD, Emmerich B. Hallek M, et al. Among authors: danhauser riedl s. Exp Hematol. 1997 Dec;25(13):1367-77. Exp Hematol. 1997. PMID: 9406996

2

Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.

Neumann C, Zehentmaier G, Danhauser-Riedl S, Emmerich B, Hallek M. Neumann C, et al. Eur J Immunol. 1996 Feb;26(2):379-84. doi: 10.1002/eji.1830260217. Eur J Immunol. 1996. PMID: 8617307

3

Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.

Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M. Danhauser-Riedl S, et al. Cancer Res. 1996 Aug 1;56(15):3589-96. Cancer Res. 1996. PMID: 8758931

4

The activation of intracellular tyrosine kinases by interferon-alpha (IFNalpha) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patients.

von Bubnoff N, Adler S, Danhauser-Riedl S, Kamp T, Nerl C, Emmerich B, Hallek M. von Bubnoff N, et al. Among authors: danhauser riedl s. Ann Hematol. 2000 Mar;79(3):119-26. doi: 10.1007/s002770050566. Ann Hematol. 2000. PMID: 10803933

5

Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells.

Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A. Hallek M, et al. Among authors: danhauser riedl s. Br J Haematol. 1996 Jul;94(1):5-16. doi: 10.1046/j.1365-2141.1996.6102053.x. Br J Haematol. 1996. PMID: 8757502

6

Molecular pathogenesis of chronic myeloid leukemia: implications for new therapeutic strategies.

Warmuth M, Danhauser-Riedl S, Hallek M. Warmuth M, et al. Among authors: danhauser riedl s. Ann Hematol. 1999 Feb;78(2):49-64. doi: 10.1007/s002770050473. Ann Hematol. 1999. PMID: 10089019 Review.

7

Interleukin 1 modulates growth of human renal carcinoma cells in vitro.

Koch I, Depenbrock H, Danhauser-Riedl S, Rastetter JW, Hanauske AR. Koch I, et al. Br J Cancer. 1995 Apr;71(4):794-800. doi: 10.1038/bjc.1995.154. Br J Cancer. 1995. PMID: 7710946 Free PMC article.

8

The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate.

Schuster C, Forster K, Dierks H, Elsasser A, Behre G, Simon N, Danhauser-Riedl S, Hallek M, Warmuth M. Schuster C, et al. Among authors: danhauser riedl s. Blood. 2003 Jan 15;101(2):655-63. doi: 10.1182/blood-2002-01-0043. Epub 2002 Sep 12. Blood. 2003. PMID: 12393654 Free article.

9

Some antagonists of platelet activating factor are cytotoxic for human malignant cell lines.

Danhauser-Riedl S, Felix SB, Houlihan WJ, Zafferani M, Steinhauser G, Oberberg D, Kalvelage H, Busch R, Rastetter J, Berdel WE. Danhauser-Riedl S, et al. Cancer Res. 1991 Jan 1;51(1):43-8. Cancer Res. 1991. PMID: 1988103

10

Cross-resistance pattern of cell lines selected for resistance towards different cytotoxic drugs to membrane-toxic phospholipids in vitro.

Himmelmann AW, Danhauser-Riedl S, Steinhauser G, Busch R, Modest EJ, Noseda A, Rastetter J, Vogler WR, Berdel WE. Himmelmann AW, et al. Cancer Chemother Pharmacol. 1990;26(6):437-43. doi: 10.1007/BF02994095. Cancer Chemother Pharmacol. 1990. PMID: 2225315

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters